Latest Distributions News

Burgundy Diamond Mines has updated its Ekati Diamond Mine Life of Mine plan through 2040, extending Misery underground operations and advancing the Fox Underground project with strong economic prospects.

Associate Global Partners Limited reported an 11% increase in funds under management to $1.397 billion for the June quarter 2025, alongside sustained positive operating cash flows and strong fund performance from its WCM strategies.

Alma Metals has bolstered its Briggs Copper JV Project with a $1.06 million capital raise and an updated resource estimate that now includes silver. The company is progressing a scoping study and preparing for significant drilling to unlock further value.

Iltani Resources has announced its maiden JORC Mineral Resource Estimate for the Orient West Silver-Indium deposit, revealing a significant 21.6 million tonnes at 100.5 g/t silver equivalent. This milestone confirms the project as Australia's largest known silver-indium resource and sets the stage for further expansion.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

xReality Group delivered a strong Q4 FY25 with $4.7 million in cash receipts, driven by growth in its Operator XR enterprise software and entertainment divisions, alongside a $2 million placement to institutional investors supporting international expansion.

Cluey Ltd has achieved its first-ever positive operating cash flow in Q4 FY25, marking a pivotal shift towards sustainable growth powered by AI innovation and expanded market reach.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

MONEYME has exceeded its FY25 operating cash profit expectations by 20%, driven by robust loan book expansion and improved credit quality, while gearing up for a major credit card launch.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

Matrix Composites & Engineering has landed a new A$10 million subsea buoyancy contract for a Gulf of Mexico project, adding to over A$45 million in awards this financial year and reinforcing its global SURF market presence.